Pavmed Inc.-CW24PAVMZPreferred / convertible
13F holders, Q1 2025 (March 31)4holders
0new positions
0sold out
1famous investor
$0.01avg. 13F price*
At the end of Q1 2025, 4 institutions reported holding Pavmed Inc.-CW24 (PAVMZ) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Susquehanna International Group, LLP ($837), Citadel Advisors ($234) and UBS Group AG ($20). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Pavmed Inc.-CW24
- CUSIP
- 70387R122
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 11,213 shares bought and 5,674 shares sold, net +5,539 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Susquehanna International Group, LLP | — | Add +8.1% | 149,408 | $837 |
| Citadel Advisors | — | Reduce -2.7% | 41,721 | $234 |
| UBS Group AG | — | Reduce -58.4% | 3,205 | $20 |
| Bank of America Corp. | — | No change | 100 | $0 |
"% of holder's portfolio" is PAVMZ's weight in each manager's 13F, not the share of Pavmed Inc.-CW24 the manager owns.